AfterRaise/Weekly/Week 3, 2026

The AfterRaise week

Week 3, 2026

69 rounds, $6.0B of announced capital. The largest: Skild AI raised $1.4B. Sorted by size; every figure links to its source.

MoveFundingObserved8 months ago
Skild AI
Growth · Pittsburgh, USA · Robotics & Manufacturing
What happened

Raised $1.4B in Growth funding, led by SoftBank Group.

The company said the funding supports continue scaling its model training and growing the future deployment of its technology across enterprise and commercial sectors.

Likely next InferredCommercial team build-outRevenue leadership appointmentsPlatform and infrastructure scaling
Where you helpEngineering hiringDistribution partnersIndustrial partnershipsRevenue leadershipChannel partners
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Parloa
Series D · Berlin, Germany · AI & Data Infrastructure
What happened

Raised $350M in Series D funding, led by General Catalyst.

The company said the funding supports continue its global expansion focused on the U.S.

Likely next InferredGlobal market entryUS market entryNew market entry
Where you helpInfrastructure and computeData partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Mirador
Series B · San Diego, USA · Biotech & Pharma
What happened

Raised $250M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAggressive multi-front expansion
Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Orca Bio
Undisclosed · Menlo Park, USA · Biotech & Pharma
What happened

Raised $250M.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringOperational scale
Where you helpClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
DC BLOX
Undisclosed · Atlanta, USA · AI & Data Infrastructure
What happened

Raised $240M.

The company said the funding supports its hyperscale data center expansion strategy across the Southeastern United States.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup
Where you helpInfrastructure and computeSecurity reviewData partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Onebrief
Series D · Honululu, USA · Enterprise Software
What happened

Raised $200M in Series D funding.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringMulti-market operations
Where you helpEnterprise salesCustomer successRevenue operationsSecurity and SOC 2Cloud infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Aspen Power
Undisclosed · NYC, USA · Energy & Climate
What happened

Raised $200M.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where you helpGrid and utility partnershipsIndustrial partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Harmattan AI
Series B · Paris, France · Defence, Space & Aerospace
What happened

Raised $200M in Series B funding, led by Dassault Aviation.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringCommercial scale-up
Where you helpCertification and airworthinessGovernment relationsSecurity clearance hiringManufacturing scale-upSupply chain
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
AirNexis Therapeutics
Series A · Palo Alto, USA · Biotech & Pharma
What happened

Raised $200M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAggressive multi-front expansion
Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
JetZero
Series B · Long Beach, USA · Other
What happened

Raised $175M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredCommercial team build-outRevenue leadership appointmentsAggressive multi-front expansion
Where you helpCommercial leadershipOperations hiringGo-to-market partnershipsRevenue leadershipChannel partners
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Alpaca
Series D · San Mateo, USA · Fintech & Insurance
What happened

Raised $150M in Series D funding, led by Drive Capital.

The company said the funding supports consolidate its global investment infrastructure in support of sophisticated financial institutions and institutional trading clients worldwide.

Likely next InferredProduct launches and new tiersProduct leadership hiringPlatform and infrastructure scaling
Where you helpBanking partnershipsData securityProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Torq
Series D · NYC, USA · AI & Data Infrastructure
What happened

Raised $140M in Series D funding.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringMulti-market operations
Where you helpInfrastructure and computeAI governanceEnterprise salesSecurity reviewModel evaluation
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
MEDIPOST
Undisclosed · Cambridge, USA · Biotech & Pharma
What happened

Raised $140M.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringOperational scale
Where you helpClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Defense Unicorns
Series B · San Antonio, USA · Defence, Space & Aerospace
What happened

Raised $136M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredAggressive multi-front expansionSenior executive hiringCommercial scale-up
Where you helpCertification and airworthinessGovernment relationsSecurity clearance hiringManufacturing scale-upSupply chain
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Deepgram
Series C · San Francisco, USA · AI & Data Infrastructure
What happened

Raised $130M in Series C funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where you helpData partnershipsProduct leadershipDesign partnersSpecialist engineeringInfrastructure and compute
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Tulip
Series D · Somerville, USA · Enterprise Software
What happened

Raised $120M in Series D funding, led by Mitsubishi Electric Corporation (TOKYO: 6503).

The company said the funding supports expand operations and its development efforts.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup
Where you helpCloud infrastructureChannel partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Mytra
Series C · Brisbane, USA · Logistics & Mobility
What happened

Raised $120M in Series C funding, led by Avenir Growth.

The company said the funding supports accelerate deployment scaling to meet customer demand and fuel strategic talent acquisition.

Likely next InferredTeam growth across core functionsSenior leadership appointmentsManufacturing capacity expansion
Where you helpCarrier and network partnershipsInfrastructure partnershipsExecutive searchTalent partnersEmployer infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Kinaset Therapeutics
Series B · Boston, USA · Biotech & Pharma
What happened

Raised $103M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAggressive multi-front expansion
Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
osapiens
Series C · Mannheim, Germany · Energy & Climate
What happened

Raised $100M in Series C funding.

The company said the funding supports accelerate product innovation and accelerate growth in existing and new international markets, and consolidate its position as a global platform for sustainable growth.

Likely next InferredGlobal market entryNew market entryFirst local hires in the new market
Where you helpGrid and utility partnershipsProject financeIndustrial partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Higgsfield
Series A · San Francisco, USA · Media & Creative
What happened

Raised $80M in Series A funding.

The company said the funding supports expand its API and marketing automation capabilities for customers building high-throughput marketing content systems.

Likely next InferredTeam growth across core functionsSenior leadership appointmentsNew market entry
Where you helpDistribution partnershipsBrand partnershipsExecutive searchTalent partnersEmployer infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Proxima
Seed · NYC, USA · Biotech & Pharma
What happened

Raised $80M in Seed funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions
Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Inquis Medical
Series C · Menlo Park, USA · Healthcare & Medtech
What happened

Raised $75M in Series C funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsMulti-market operationsExecutive appointments
Where you helpClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Wasabi
Undisclosed · Boston, USA · Other
What happened

Raised $70M.

The announcement did not set out what the funding supports.

Likely next InferredPlatform and infrastructure scalingInfrastructure hiringAccelerated hiring across functions
Where you helpGo-to-market partnershipsPlatform engineeringCloud and compute partnersSecurity reviewCommercial leadership
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Accelsius
Series B · Austin, USA · Semiconductors & Hardware
What happened

Raised $65M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsCommercial scale-upNew market preparation
Where you helpSupply chainFoundry and fabricationCertificationHardware engineeringProcurement
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Vibrant Therapeutics
Undisclosed · USA · Biotech & Pharma
What happened

Raised $61M.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsOperational scaleMarket consolidation
Where you helpClinical operationsRegulatory affairsCMC and manufacturingQuality systemsMedical affairs
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Aikido Security
Series B · UK · Other
What happened

Raised $60M in Series B funding, led by DST Global.

The company said the funding supports accelerate global expansion, and invest in engineering and go-to-market talent.

Likely next InferredGlobal market entryTeam growth across core functionsSenior leadership appointments
Where you helpCommercial leadershipOperations hiringGo-to-market partnershipsExecutive searchTalent partners
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Cytotheryx
Series A · Rochester, USA · Biotech & Pharma
What happened

Raised $60M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions
Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
WitnessAI
Undisclosed · Mountain View, USA · Cybersecurity
What happened

Raised $58M.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where you helpChannel partnershipsThreat intelligence partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
bit.bio
Undisclosed · Cambridge, UK · Biotech & Pharma
What happened

Raised $50M, led by M&G Investments.

The company said the funding supports accelerate the development of, and access to, its products, scale its operations globally, expand into the toxicology market, bolster its manufacturing operations, and generate new datasets for AI model training.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup
Where you helpCMC and manufacturingQuality systemsLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Positive Development
Debt · McLean, USA · Healthcare & Medtech
What happened

Raised $45M in Debt funding.

The company said the funding supports expand developmental therapy and autism diagnostics services into new and existing geographies across the United States, pursue strategic acquisitions, and increase access to care for families through health plans.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup
Where you helpProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsCorporate finance advisers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
VieCure
Undisclosed · Denver, USA · Biotech & Pharma
What happened

Raised $43M.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where you helpLicensing and BD partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical operations
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
WithCoverage
Series B · NYC, USA · Legal & Compliance
What happened

Raised $42M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where you helpProfessional services partnershipsProduct leadershipDesign partnersSpecialist engineeringEnterprise sales
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
depthfirst
Series A · San Francisco, USA · Other
What happened

Raised $40M in Series A funding, led by Accel.

The company said the funding supports support its research and development, GTM efforts, and hiring across applied research, engineering, product, and sales.

Likely next InferredAccelerated hiring across functionsCommercial scale-upNew market preparation
Where you helpInfrastructure and computeAI governanceEnterprise salesSecurity reviewModel evaluation
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Midnite
Series C · London, UK · Consumer & Retail
What happened

Raised $35M in Series C funding, led by Raine Partners IV.

The company said the funding supports scale operations, accelerate development of products and support international expansion.

Likely next InferredGlobal market entryNew market entryFirst local hires in the new market
Where you helpRetail partnershipsBrand leadershipMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Juvena Therapeutics
Series B · Redwood City, USA · Biotech & Pharma
What happened

Raised $34M in Series B funding.

The announcement did not set out what the funding supports.

Likely next InferredResearch programme expansionScientific team growthAccelerated hiring across functions
Where you helpClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
HPS/PayMedix
Debt · Milwaukee, USA · Healthcare & Medtech
What happened

Raised $33M in Debt funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsOperational scaleMarket consolidation
Where you helpClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
GovDash
Series B · NYC, USA · AI & Data Infrastructure
What happened

Raised $30M in Series B funding, led by Mucker Capital and British Columbia Investment Management Corporation (BCI).

The company said the funding supports expand its engineering teams across all product areas, invest in customer success, and grow its office presence in New York and Arlington, Virginia.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup
Where you helpInfrastructure and computeData partnershipsProduct leadershipMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Quadric
Series C · Burlingame, USA · Semiconductors & Hardware
What happened

Raised $30M in Series C funding, led by ACCELERATE Fund.

The company said the funding supports expand operations and its development efforts.

Likely next InferredNew market entryFirst local hires in the new marketLocal entity and legal setup
Where you helpIndustrial partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsSupply chain
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Trybe
Series A · London, USA · Enterprise Software
What happened

Raised $30M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsRepeatable go-to-market buildFirst senior commercial hires
Where you helpEnterprise salesCustomer successRevenue operationsSecurity and SOC 2Cloud infrastructure
Approach preferences not yet specified
Company roomSource
MoveFundingObserved8 months ago
Ventaris Surgical
Series A · San Carlos, USA · Healthcare & Medtech
What happened

Raised $30M in Series A funding.

The announcement did not set out what the funding supports.

Likely next InferredAccelerated hiring across functionsRepeatable go-to-market buildFirst senior commercial hires
Where you helpClinical evidenceRegulatory affairsReimbursement and market accessHospital procurement experienceQuality systems
Approach preferences not yet specified
Company roomSource

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.